This is a market research notice to determine an acquisition strategy for a potential future contract to supply Cepheid-brand reagents and consumables for a specific analyzer at the Cincinnati VA Medical Center. The potential contract would be for a base year plus four one-year options. The required products are proprietary cartridges for testing influenza, RSV, COVID-19, and Strep A. The government is seeking capability statements from businesses to determine if a small-business set-aside is appropriate under NAICS code 325413. Responses are required via email by 12:00 PM EDT on Tuesday, March 24, 2026.